- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- Women, early-career scientists hardest hit by NIH grant terminations: Study
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- California peer-run behavioral health center to close amid funding shift
- White House delays CDC director nomination
- Vandalia Health restructures, eliminates regional CEO roles
- ‘Integration only works if data lives in the same system’: How 5 systems are operationalizing behavioral health
- Medicaid work requirements could cut enrollment by up to 10 million per month
- Medicaid work requirements could shrink enrollment by up to 10 million people in any given month
- Inside UHS’ playbook for responsible behavioral health growth
- Adventist Health hospital names president
- Epic4 Specialty Partners adds Illinois practice
- Residents, fellows tap Mayo Clinic Platform data for insights
- NYC Health + Hospitals to end $4M Palantir contract
- Ascension drives quality, access wins with ‘digital nudges’
- Adventist Health cuts operating loss in 2025
- Adventist Health cuts operating loss in 2025
- 10 surgeons making headlines in 1 month
- Infosys to acquire Optimum Healthcare IT for $465M
- ‘Burning the candle from both ends’: New York hospital CFO on rising costs, revenue cuts
- ASCs are not hospitals — and 1 administrator says the industry is forgetting that
- The unsolved problems still plaguing dentistry
- American Dental Association adds mental health, GLP-1 prompts to patient forms
- 21 revenue cycle executive moves in 2026
- ASCA backs outpatient surgery access bill
- The outpatient explosion is here—can real estate keep up?
- North Carolina orthodontic practice opens 7th location
- The health systems with the top supply chain operations and 4 more updates
- Intuitive Surgical eyes ASCs as robotics’ next frontier
- Feds give first-ever green light to ASC estate planning ownership model
- Virginia hospital boosts workplace safety reporting 245% with 3 strategic shifts
- What’s next for Optum?
- The 47 rural emergency hospitals, by state
- Massachusetts payers, hospitals partner on care affordability, access
- Pennsylvania hospital to end inpatient, ED services in May
- ADA urges CMS to proceed with adult dental coverage expansion
- Where anesthesiology residents are headed: 2026 Match data by state
- California outpatient medical office building sold for $340M
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- Imagen Dental Partners adds Washington practice
- Imagen Dental Partners appoints senior VP of M&A
- Arkansas man charged with making terroristic threats to dental office staff
- Smile Partners appoints DSO veteran as COO
- Financial challenges slam dental offices: 4 updates
- Dental innovation continues: 10 big updates to know
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Tennessee hospital files notice tied to vendor transition affecting 85 workers
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- AI-driven RCM firm Adonis raises $40M
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Rush Health anticipates $5.9M in revenue from automated coding
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Scaling patient access the right way: The Stella-Nanonets blueprint
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- CMS unveils new pediatric care model
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Two-thirds of pediatric mental health triage scores inaccurate: Study
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Idaho lawmakers push to restore mental health programs
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- New York launches mental health training for first responder clinicians
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
- Cologuard campaign reunites ‘Full House’ stars to give ‘The Talk’ about colon cancer screening
- Lilly to remove certain insulin products from European markets by 2027
- Karyopharm, looking to jump-start Xpovio, reports mixed results in myelofibrosis
- Study Warns Fluoride Bans May Raise Tooth Decay in Children
- WuXi Bio's record number of new projects in 2025 leaned heavily on US clients
- “Me engañaron”: agentes encadenan a un padre que había ido al ICE a reunirse con sus hijos
- Gilead inks Manta pact to dive deeper into cancer patient support
- Cheap Children's Clothing Tainted With Lead, Study Says
- Insulin Prices Fell For Medicare Patients Under Biden-Era Caps, Study Finds
- New Fathers Face Mental Health Challenges, Study Finds
- Your Choice Of Booze Influences Your Risk Of Death, Study Says
- AI Gets a 'D' When Judging Scientific, Medical Claims
- New Online Tool Helps Parkinson's Patients Weigh Brain Implant Decision
- AI chatbot use for health information up 16% from 2024: Rock Health survey
- ‘They Tricked Me’: A Father Was Chained After He Went to ICE To Reunite With His Kids
- Wilmington PharmaTech commits $50M to US API expansion
- Strides recalls nearly 90K bottles of children's ibuprofen after contamination complaints
- Trump administration unveils national policy framework for AI as it moves to override state laws
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- 17 spine surgery firsts in Q1
- 17 spine surgery firsts in Q1
- Cencora acquiring EyeSouth Partners' retina business for $1.1B
- Aunque tengas seguro dental, la factura puede ser muy alta
- Massive class action seeking RICO penalties against Takeda, Lilly presses forward with SCOTUS order
- A look at how Optum Rx is using AI to address pharmacy fraud, waste and abuse
- AbbVie steps up to the plate as official pharma sponsor of MLB
- Gilead CEO Daniel O'Day nets $28.4M pay package as security and travel costs top $2M
- Nursing Homes Accused of False Diagnoses To Hide Drug Use
- FDA Approves Higher-Dose Wegovy To Help People Lose More Weight
- Teens Often Pressured To Send Sexual Photos by Someone They Know, Study Finds
- CommonSpirit, Humana reach 3-year national network agreement
- Match Day 2026: Growth in emergency medicine, psychiatry
- Nearly 90,000 Bottles of Children’s Ibuprofen Recalled Nationwide
- FTC launches multi-bureau Healthcare Task Force to spot 'new priority areas for enforcement'
- Algunos adultos de mediana edad deciden posponer la atención médica hasta tener Medicare
- ¿Qué tan bajo se puede llegar? Las cambiantes guías para el control de la presión arterial
- EyePoint lawsuit accuses Ocular of 'malicious' defamation campaign in retina drug race
- Rural hospitals could apply for temporary interest-free construction, renovation loans under new bipartisan bill
- Cost Center to Command Center: How Health Systems Are Systematizing Innovation in Support Services
- Rural Residents Have Highest Cancer Death Rates, Researchers Say
- Your Bank Account Might Show How Well Your Brain Will Age, Researchers Say
- Insurance Lapses Play Havoc With Diabetes Management, Study Shows
- Psychedelics Aren't Better Than Antidepressants In Treating Depression, Review Concludes
- A Nasal Swab for Alzheimer's? Duke Team Has One in Testing
- Heat Advisories Might Not Trigger Soon Enough For Some Seniors, Study Finds
- Don't Forget This: Study Shows Cannabis Exacts a Toll on Your Memory
- Want To Stress Less? Start With These Everyday Habits
- Large pharma companies reduced headcounts by more than 22K in 2025 as $300B patent cliff looms
- Remarks at The SEC Speaks in 2026: From Kitchen Table to Cap Table—Making Capital Formation Work for Small Businesses
- Health system AI adoption surges in 2026 with execs reporting increased ROI: survey
- Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds
- Survey Shows More People Struggling To Afford ACA Insurance
- Up to 155,000 COVID Deaths May Not Have Been Counted, Study Finds
- FDA Drops Plan To Ban Tanning Beds for Minors Nationwide
- Mindray North America Enters Ventilator Market
- Mindray North America Enters Ventilator Market
The Manhattan Institute is a respected center-right think tank best known for their City-Journal website. Chris Pope, a senior fellow at the Manhattan Institute, has written a thoughtful piece on managing skyrocketing Medicaid costs into the future:
https://thehill.com/opinion/healthcare/4022852-a-better-way-to-rein-in-medicaid/
A better way to rein in Medicaid
By Chris Pope - May 30, 2023Medicaid is two things at once: a health care benefit for poor individuals, and a system of federal grants that disproportionately profits wealthy states.
Over the past four decades, Medicaid spending has grown more than any other category of public expenditure. Republicans have tried to rein in the cost of the program with “block grants” and “per capita caps.” But these would leave states short of funds in recessions, threatening state budgets and coverage for low-income beneficiaries when assistance is most needed. As a result, Congress has repeatedly rejected these proposals — even under unified GOP control.
A better approach would be to gradually federalize responsibility for covering individuals that states must enroll in Medicaid, while leaving states to pay for whatever additional benefits they choose to provide out of their own funds.
Medicaid has been the fastest growing government program over recent years, expanding from 0.5 percent of gross domestic product in 1985 to 2.4 percent of GDP in 2022. This is partly due to the general increase in health care costs, but mostly the product of substantial expansions in eligibility. Medicare’s enrollment surged from 20 million in 1985 to 86 million in 2021 — an increase from 8 percent to 26 percent of the U.S. population.
Over that period, the expansion of Medicaid contributed to a decline from 15 percent to 11 percent in the proportion of the U.S. population that lacks health insurance. But one study estimated that for 60 percent of those newly enrolled, expansions of Medicaid coverage had simply served to displace private insurance.
Medicaid is largely structured and operated by states, with funding mostly provided by the federal government. States can claim between $1 and $9 in federal funds for every $1 they spend on the program for eligible beneficiaries, which gives them a great incentive to expand the program as much as they can. The wealthiest states with the deepest tax bases have been most able to take advantage of this arrangement: Alaska claimed $21,445 in federal Medicaid funding per resident in poverty in 2021, whereas Nevada received only $8,402. During economic expansions, states have used growing revenues to expand Medicaid, and repeatedly prodded Congress to bail them out in subsequent recessions.
For decades, congressional Republicans have sought to rein in Medicaid costs by capping federal matching aid each state can claim for each beneficiary. (This was how grants to states under the Social Security Act were all initially structured.) But this proposal has repeatedly run into a combination of substantive objections and political obstacles, which are unlikely to disappear.
Opponents have argued that capping Medicaid grants to states would threaten the funding of health care for the neediest beneficiaries. This problem would be particularly acute in recessions, when state tax revenues decline just as their Medicaid caseloads increase — exacerbating the bailout dynamic. It would also leave states in a bind if medical costs suddenly surged beyond their fiscal capacities. As proposed caps have been based on historical spending, traditionally low-spending states would have become subject to the tightest constraints. This has made per capita caps unpopular with many Republican governors as well as Democrats.
To meet these objections, the proposed caps considered (and rejected) by the Republican Congress in 2017 were so watered down that they would have been entirely ineffectual. They would have limited the growth of federal Medicaid grants to 3.7 percent per enrollee per year, even though spending had only grown at 2.0 percent per year over the previous 16 years. Nor would per enrollee caps have done anything to constrain the cost of expanding enrollment, which is the main driver of rising expenditure.
Reformers would achieve more by distributing Medicaid funds according to the needs of individuals, rather than in proportion to the resources that states are able to contribute.
To claim federal Medicaid funds, states are currently required to cover a core package of services (hospital, physician and nursing home care) for groups of mandatory beneficiaries (such as pregnant women, the disabled and children with incomes below the poverty line). They may also claim federal funds at the same matching rate to provide additional services (such as optical or dental care) and for expanding eligibility to individuals with incomes up to 380 percent of the federal poverty line.
Across the country, federal payments to states amount to 125 percent of the cost of mandatory Medicaid spending. But while federal assistance for mandatory Medicaid spending is fairly uniform across states, the wealthiest states claim several times more than the poorest in grants for optional benefits. Whereas Nevada in 2013 received federal payments covering 85 percent of the cost of benefits it was required to provide, the District of Columbia was able to claim 203 percent.
The core problem with Medicaid is the separation between control over the cost of the program (the scope of benefits, fees paid for them and the breadth of eligibility) and the responsibility for paying for it. Ideally, the federal government should directly operate and fully fund mandatory Medicaid benefits, and let states fully fund any additional benefits they choose to provide out of their own resources.
Such an arrangement would represent a big change from the status quo; thus, a more incremental reform path to get there is necessary.
To achieve this, federal payments to each state should be capped at either (1) 100 percent of the cost of providing core benefits to mandatory enrollees, or (2) the current per resident level of federal funding in nominal terms — whichever is higher. States should be allowed waivers to claim federal funds at a higher matching rate to fund mandatory spending by reducing federal aid claimed for optional spending by an equivalent amount.
This reform would focus federal Medicaid spending on the provision of core benefits for the neediest enrollees. Rather than leaving states short of funds in recessions when program costs increase, it would make the federal government largely responsible for costs resulting from increased enrollment among core eligibility groups in such circumstances.
Yet, such a reform would eliminate the incentive for states to expand the cost of Medicaid at the expense of the federal government. Over time, it would reduce real federal Medicaid spending by 20 percent, as inflation erodes the real value of grants to states where spending on optional benefits exceeds the full cost of mandatory spending. The reduction in federal spending would be limited to optional benefits and concentrated on the wealthiest states. By harmonizing benefits and reducing the disparity in assistance to states over time, this would facilitate the eventual full federalization of the program.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

















